Global Innovative Platforms Inc. (GIPL): Shareholders' Equity

Annual figures by period end, from SEC filings.

$187.7K
As of 2025-09-30
$531.5K
As of 2026-06-30
2021-09-30: -$28.9K2022-09-30: -$82.7K2023-09-30: -$364.0K2024-09-30: -$33.1K2025-09-30: $187.7K$187.7K
2021-09-30 Shareholders' Equity (USD) 2025-09-30
Period endedShareholders' EquityChange YoYSource filing
2025-09-30$187.7Kn/m2026-01-13, Balance as of period end
2024-09-30-$33.1Kn/m2026-01-13, Balance as of period end
2023-09-30-$364.0Kn/m2024-12-30, Balance as of period end
2022-09-30-$82.7Kn/m2024-08-23, Balance as of period end
2021-09-30-$28.9Kn/a2023-03-10, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Global Innovative Platforms Inc. (GIPL)2025-09-30$187.7Kn/m
Baxter International Inc (BAX)2025-12-31$6.10B-13.1%
Becton Dickinson & Co (BDX)2025-09-30$25.39B-1.9%
3M Co (MMM)2025-12-31$4.75B+21.9%
Teleflex Inc (TFX)2025-12-31$3.12B-27.0%
West Pharmaceutical Services Inc (WST)2025-12-31$3.18B+18.4%
Stryker Corp (SYK)2025-12-31$22.42B+8.7%
Haemonetics Corp (HAE)2026-03-28$796.32M-3.0%
KORU Medical Systems, Inc. (KRMD)2025-12-31$17.05M+1.4%

Compare GIPL, BAX, BDX, MMM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗